Last $41.15 USD
Change Today -0.23 / -0.56%
Volume 543.9K
SGEN On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 09/18/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jonathan Drachman M.D.

Chief Medical Officer and Executive Vice President of Research & Development, Seattle Genetics Inc.
AgeTotal Calculated CompensationThis person is connected to 9 board members in 1 different organizations across 1 different industries.

See Board Relationships
--$2,168,736
As of Fiscal Year 2013

Background*

Dr. Jonathan Drachman, also known as John, has been Chief Medical Officer and Executive Vice President of Research & Development at Seattle Genetics Inc. since October 2013. Dr. Drachman served as Senior Vice President of Research and Translational Medicine at Seattle Genetics Inc. He served as its Senior Medical Director. Dr. Drachman is a Member of Scientific Advisory Board of Integra Ventures. He is also a UW Associate Professor. Dr. Drachman holds an M.D. degree. ...

Read Full Background

Corporate Headquarters*

21823 30th Drive SE
Bothell, Washington 98021

United States

Phone: 425-527-4000
Fax: 425-527-4001

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BA
Harvard University
MD
Harvard Medical School

Other Affiliations*

Annual Compensation*

Salary$383,267
Total Annual Compensation$383,267

Stock Options*

Restricted Stock Awards$904,041
All Other Compensation$8,130
Exercised Options93,294
Exercised Options Value$2,695,078
Exercisable Options274,527
Exercisable Options Value$7,541,750
Unexercisable Options96,679
Unexercisable Options Value$1,247,505
Total Value of Options$11,484,333
Total Number of Options464,500

Total Compensation*

Total Annual Cash Compensation$572,261
Total Short Term Compensation$383,267
Other Long Term Compensation$912,171
Total Calculated Compensation$2,168,736
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SGEN:US $41.15 USD -0.23

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Daniel G. Welch Chairman, Chief Executive Officer and President
InterMune, Inc.
$703.4K
Simon E. Moroney Ph.D.Chairman of Management Board and Chief Executive Officer
Morphosys AG
€772.6K
Jan G. J. van de Winkel Ph.D.Co-Founder, Chief Executive Officer and President
Genmab A/S
kr10.7M
David T. Hung M.D.Founder, Chief Executive Officer, President and Executive Director
Medivation, Inc.
$750.0K
Michael L. Babich Chief Executive Officer, President and Director
INSYS Therapeutics, Inc.
$1.0M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SEATTLE GENETICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.